Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$60.03 +0.16 (+0.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Operating Income (2009 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) reported Operating Income of $110.92 million for Q2 2026, down 59.9% from $276.89 million a year earlier and down 14.4% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Operating Income (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Biomarin Pharmaceutical's Operating Income came in at $149.26 million, down 80.8% year-over-year; for FY2025, it was $409.48 million, down 15.4% from FY2024.

  • By year, Operating Income came in at $484.21 million in FY2024 (+160.6%), $185.77 million in FY2023 (+15.4%), $160.97 million in FY2022 and -$82.34 million in FY2021.
  • Five-year quarterly Operating Income spans a low of -$65.88 million in Q4 2021 and a high of $276.89 million in Q2 2025.
  • Year over year, Operating Income gained in four of the last six quarters, with growth averaging 157.6%.
  • The high point for year-over-year Operating Income in five years was Q4 2024 (growth of 491.7%); the low point was Q2 2026 (a decline of 59.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $129.64 million (Q1 2026), -$44.61 million (Q4 2025) and -$46.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 7.14 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 6.43 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 3.16 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.25 Bn
10 Biomarin Pharmaceutical 11.59 Bn 5.45 Bn 786.91 Mn 110.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 110.92 Mn
Mar 31, 2026 129.64 Mn
Dec 31, 2025 -44.61 Mn
Sep 30, 2025 -46.69 Mn
Jun 30, 2025 276.89 Mn
Mar 31, 2025 223.89 Mn
Dec 31, 2024 161.41 Mn
Sep 30, 2024 113.89 Mn
Jun 30, 2024 120.45 Mn
Mar 31, 2024 88.46 Mn
Dec 31, 2023 27.28 Mn
Sep 30, 2023 30.53 Mn
Jun 30, 2023 65.57 Mn
Mar 31, 2023 62.40 Mn
Dec 31, 2022 -13.09 Mn
Sep 30, 2022 -2.42 Mn
Jun 30, 2022 39.15 Mn
Mar 31, 2022 137.33 Mn
Dec 31, 2021 -65.88 Mn
Sep 30, 2021 -53.22 Mn
API Access

Biomarin Pharmaceutical Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=BMRN&period=max&api_key=YOUR_API_KEY